Criteria to identify appropriate candidates for CRT and CRT-D are based on the experiences gained during clinical trials ( Table II). Trials to date have predominantly included patients with ...

Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for the OmniaSecure defibrillation lead for ...

The US FDA has granted approval for Medtronic’s OmniaSecure defibrillation lead intended for insertion in the right ...

The choice between ICD types still should be based on each individual patient’s risk factors, Kenneth Ellenbogen says.

Empowering Physicians, Powering Hearts. "We're delighted for the heart failure patients who were not treatable with existing CRT lead-based devices," said John McCutcheon, President and CEO of EBR ...

"Recent years have brought significant advancements in leadless pacing for the right heart, but CRT patients were limited ... syncs with existing pacing devices—pacemakers, ICDs, or CRTs ...